WilmerHale advised TMX on the deal. TMX Group Limited, an international financial services company, announced that it has closed an equity investment to acquire a minority...
TMX’s Minority Investment of SigmaLogic
LeveL ATS’ Merger with Luminex
LeveL was represented in the transaction by the investment banking team at Rosenblatt Securities as its exclusive financial advisor and WilmerHale and Schulte Roth & Zabel...
SDC Capital Partners’ Investment in IQ Fiber
Morgan Lewis represented IQ Fiber in the transaction while Wilmer Cutler Pickering Hale and Dorr advised SDC Capital Partners. SDC Capital Partners, LLC (“SDC”) announced that...
Symphony’s Acquisition of Cloud9 Technologies
Goodwin Procter LLP advised Symphony on the deal while Wilmer Cutler Pickering Hale and Dorr represented Cloud9 Technologies. Symphony announced its acquisition of Cloud9 Technologies. Symphony is...
Verve Therapeutics’ $306 Million IPO
Wilson Sonsini Goodrich & Rosati advised Verve Therapeutics on the deal. Verve Therapeutics (Nasdaq: VERV), a biotech company pioneering a new approach to the care of...
Amplitude Healthcare’s Business Combination with Jasper Therapeutics
Wilmer Cutler Pickering Hale and Dorr advised Amplitude Healthcare Corporation on the deal while Paul Hastings represented Jasper Therapeutics. Amplitude Healthcare Corporation (Nasdaq: AMHC), a special...
Sanofi’s Acquisition of Tidal Therapeutics
Wilmer Cutler Pickering Hale and Dorr LLP advised Sanofi on the deal. Sanofi, a global biopharmaceutical company focused on human health, announced its acquisition of Tidal...